Men with intermediate or high-risk localised prostate cancer should be given a
combination of radical radiotherapy and androgen deprivation therapy, rather than
radical radiotherapy or androgen deprivation therapy alone, recommends newly
updated guidance [] from the National Institute of Health
and Care Excellence (NICE), published today.

Read the article.

Leave a Comment

Scroll to Top